DONGGUAN SHUOLEI E-COMMERCE CO., LTD. – Trademark Portfolio

Entity Type: 99

DONGGUAN SHUOLEI E-COMMERCE CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BUNKELL. The owner is based in DONGGUAN,GUANGDONG.

RM 302, BLDG 2, FENGGANG TIANAN DIGITAL CITY, NO. 208, FENGGANG SECTION, DONGSHEN RD., FENGGANG TOWN

DONGGUAN,GUANGDONG 523000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BUNKELL
BUNKELL
Registered 2020

Trademark Classifications

DONGGUAN SHUOLEI E-COMMERCE CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does DONGGUAN SHUOLEI E-COMMERCE CO., LTD. have?

DONGGUAN SHUOLEI E-COMMERCE CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does DONGGUAN SHUOLEI E-COMMERCE CO., LTD. file in?

DONGGUAN SHUOLEI E-COMMERCE CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DONGGUAN SHUOLEI E-COMMERCE CO., LTD.'s most well-known trademarks?

DONGGUAN SHUOLEI E-COMMERCE CO., LTD.'s registered trademark portfolio includes well-known marks such as BUNKELL. These are among 1 currently registered trademark in the portfolio.

What is DONGGUAN SHUOLEI E-COMMERCE CO., LTD.'s trademark registration success rate?

DONGGUAN SHUOLEI E-COMMERCE CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.